Genetics of exceptional longevity: possible role of GM allotypes

[1]  A. Namboodiri,et al.  Association of immunoglobulin GM allotypes with longevity in long-living individuals from Southern Italy , 2018, Immunity & Ageing.

[2]  C. Caruso,et al.  Centenarians as a model to discover genetic and epigenetic signatures of healthy ageing , 2018, Mechanisms of Ageing and Development.

[3]  C. Caruso,et al.  Autoimmune diseases and 8.1 ancestral haplotype: An update , 2018, HLA.

[4]  C. Caruso,et al.  Association between γ marker, human leucocyte antigens and killer immunoglobulin‐like receptors and the natural course of human cytomegalovirus infection: a pilot study performed in a Sicilian population , 2018, Immunology.

[5]  P. Sebastiani,et al.  Limitations and risks of meta-analyses of longevity studies , 2017, Mechanisms of Ageing and Development.

[6]  C. Franceschi,et al.  Ageing, longevity, exceptional longevity and related genetic and non genetics markers: panel statement. , 2014, Current vascular pharmacology.

[7]  J. Pandey,et al.  Human immunoglobulin constant heavy G chain (IGHG) (Fcγ) (GM) genes, defining innate variants of IgG molecules and B cells, have impact on disease and therapy. , 2013, Clinical immunology.

[8]  A. Puca,et al.  The application of genetics approaches to the study of exceptional longevity in humans: potential and limitations , 2012, Immunity & Ageing.

[9]  Paola Sebastiani,et al.  Genome-Wide Association Studies (GWAS) , 2019, Definitions.

[10]  G. Pawelec,et al.  Human immunosenescence: is it infectious? , 2005, Immunological reviews.

[11]  G. Pawelec,et al.  Is immunosenescence infectious? , 2004, Trends in immunology.

[12]  C. Franceschi,et al.  Immunogenetics of longevity. Is major histocompatibility complex polymorphism relevant to the control of human longevity? A review of literature data , 2001, Mechanisms of Ageing and Development.

[13]  C. Franceschi,et al.  HLA, aging, and longevity: a critical reappraisal. , 2000, Human immunology.

[14]  J. Lederberg.  J. B. S. Haldane (1949) on infectious disease and evolution. , 1999, Genetics.

[15]  S. Hazout,et al.  Pattern of gradient of apolipoprotein E allele *4 frequencies in western Europe. , 1997, Human biology.

[16]  C. Berek,et al.  An idiotypic determinant formed by both immunoglobulin constant and variable regions , 1983, Nature.

[17]  I. Mackay,et al.  RElation of the human antibody response to flagellin to GM genotype. , 1971, Journal of immunology.

[18]  C. Caruso,et al.  Updates in Pathobiology: Causality and Chance in Ageing,Age-Related Diseases and Longevity , 2017 .

[19]  Toshiko Tanaka,et al.  GWAS of longevity in CHARGE consortium confirms APOE and FOXO3 candidacy. , 2015, The journals of gerontology. Series A, Biological sciences and medical sciences.

[20]  J. Crow,et al.  . B . S . Haldane ( 1949 ) on Infectious Disease and Evolution , 2006 .

[21]  P. Froguel,et al.  Genetic associations with human longevity at the APOE and ACE loci , 1994, Nature Genetics.